Connection
Tanja Fehm to Norethindrone
This is a "connection" page, showing publications Tanja Fehm has written about Norethindrone.
Connection Strength
0,199
-
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Menopause. 2013 May; 20(5):504-10.
Score: 0,115
-
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas. 2013 Oct; 76(2):129-33.
Score: 0,029
-
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecol Endocrinol. 2013 Feb; 29(2):160-3.
Score: 0,028
-
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric. 2012 Oct; 15(5):467-72.
Score: 0,027
